Skip to main content

Older adults

Diabetic complications

02-24-2023 | Risk factors | News

Mortality risk factors vary by age in type 2 diabetes

Hypertension has the largest impact on mortality risk in younger people with type 2 diabetes, whereas chronic kidney disease is a greater threat for older people, shows a population-based study.

Senior man with glucometer checking blood sugar

11-29-2022 | Older adults | News

Call to rethink CGM advice for older adults

Analysis of participants in the ORACL trial leads researchers to suggest that nonfrail older adults with type 1 diabetes are better off following time in range guidance aimed at younger people.

04-19-2022 | Older adults | News

Sustained benefits of CGM in older people with type 1 diabetes

Follow-up results from the WISDM trial show that extended use of continuous glucose monitoring leads to reduced hypoglycemia without increasing hyperglycemia risk in older people with type 1 diabetes.

02-14-2022 | Older adults | News

Type 1 diabetes duration linked to clinical, functional status in older adults

Older adults with a longer duration of type 1 diabetes have an increased likelihood of experiencing depression and hypoglycemia unawareness, researchers report.

11-04-2021 | Older adults | News | Article

Hospital discharge not best time to intensify diabetes medication in older adults

Intensification of diabetes medications in older adults at the point of discharge from hospital is associated with an increased risk for hypoglycemia, without gains in glycemic control, research suggests.

05-27-2021 | Older adults | News

Frailty upsets risk–benefit balance of intensive type 2 diabetes treatment

Researchers find diminished cardiovascular gains and an increased risk for severe hypoglycemia in frail people with type 2 diabetes given intensive glycemic and blood pressure treatment.

03-31-2021 | Older adults | News

Glargine-300 might be preferable for older people with type 2 diabetes

Analysis of older participants in the BRIGHT trial suggests that this subgroup may do slightly better with insulin glargine-300 than with degludec.

11-24-2020 | Older adults | News

Age has no impact on CV outcomes with linagliptin vs glimepiride

Cardiovascular event rates do not differ significantly among people with type 2 diabetes treated with linagliptin or glimepiride regardless of age, but those who receive linagliptin have lower risks for falls and hypoglycemia, CAROLINA trial data show.

10-16-2020 | Older adults | News

Metformin use might have neuroprotective effects in older patients with type 2 diabetes

Results from an observational study suggest that the use of metformin in older patients with type 2 diabetes is associated with a reduced decline in both global cognition and executive function, and a decreased risk for dementia.

09-23-2020 | EASD 2020 | Conference coverage | News

Polypharmacy linked to adverse outcomes in people with type 1 diabetes

Study findings presented at the virtual 56th EASD Annual Meeting indicate that polypharmacy is common among people with type 1 diabetes and is associated with an increased risk for adverse outcomes.

Irl Hirsch

08-25-2020 | Psychosocial care | Video | Article

Type 1 diabetes and psychosocial care

Irl Hirsch talks about the challenges presented by psychosocial problems related directly and indirectly to having type 1 diabetes.

emergency_department

08-03-2020 | Hypoglycemia | Highlight | News

Severe hypoglycemia ‘marker rather than cause’ for longer-term type 2 diabetes mortality risk

Severe hypoglycemia in people with type 2 diabetes is associated with later mortality from a wide range of causes, including those for which there is no obvious underlying mechanism, say researchers.

CGM

06-17-2020 | Continuous glucose monitoring | Highlight | News

Variable CGM benefits in high-risk subgroups

Continuous glucose monitoring is well accepted and reduces time in hypoglycemia among older individuals with type 1 diabetes, report researchers in JAMA.

02-12-2020 | Older adults | News

Increasing comorbidity linked to poorer care quality for older people with diabetes

The quality of care among older adults with diabetes declines with increasing comorbidity and is particularly low for those with both osteoarthritis and major depression, population-based study data show.

01-15-2020 | Older adults | News

Severe hypoglycemia adversely affects brain health of older people with type 1 diabetes

Severe hypoglycemia may treble the risk for impaired cognitive function in older adults with type 1 diabetes, shows an analysis of data from the Study of Longevity in Diabetes.

11-25-2019 | Continuous glucose monitoring | News

CGM may be feasible in older people with memory problems

Findings from a UK feasibility study suggest that continuous glucose monitoring is an acceptable approach for older people with diabetes and memory problems, but devices with automated transfer of glucose readings may be needed to improve completeness of data capture.

Elderly woman with medication (symbolic image with model)

11-06-2019 | Older adults | Case study | Article

Diabetes treatment in the elderly: Kathryn

Primary care physician Jay Shubrook shares his recommendations for diabetes management in a 72-year-old, multi-morbid patient.

09-24-2019 | Type 2 diabetes | Podcast | Article

How was it for you? The experts discuss EASD 2019

Our clinical advisors discuss their EASD 2019 highlights, including new treatment options for children and older adults with type 2 diabetes, the complexities surrounding hypoglycemia prevention, and the implications of the VERIFY trial.

08-16-2019 | Linagliptin | News

Add-on linagliptin improves glycemic control in older people with type 2 diabetes

The addition of linagliptin to stable insulin treatment improves glycemic control without increasing the risk for clinically important hypoglycemia among older individuals with type 2 diabetes, randomized trial findings suggest.

07-11-2019 | Insulin glargine | News

Support for Gla-300 use in older people with type 2 diabetes

Older type 2 diabetes patients receiving basal insulin treatment who switch to glargine 300 units/mL experience greater or similar improvements in glycemic control compared with those switching to a first-generation basal insulin, with lower hypoglycemia risk, researchers report.